Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-03
DOI
10.1007/s40262-019-00764-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ending the Global Tuberculosis Epidemic by 2030 — The Moscow Declaration and achieving a Major Translational Change in Delivery of TB Healthcare
- (2017) Eskild Petersen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction
- (2016) Maxwell T. Chirehwa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
- (2016) Meredith Milstein et al. BMC INFECTIOUS DISEASES
- Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome
- (2016) Y.-M. Ye et al. BRITISH JOURNAL OF DERMATOLOGY
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients
- (2016) Vycke Yunivita et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India
- (2016) A. K. Hemanth Kumar et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period
- (2016) R. J. Bright-Thomas et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
- (2016) A. Dorothee Heemskerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
- (2015) Martin J. Boeree et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis
- (2015) Marieke G. G. Sturkenboom et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi
- (2015) J. J. van Oosterhout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exposure to Total and Protein-Unbound Rifampin Is Not Affected by Malnutrition in Indonesian Tuberculosis Patients
- (2015) L. H. M. te Brake et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells—using rifampicin as an example
- (2015) Oskar Clewe et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis
- (2015) Lindsey te Brake et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment
- (2015) A. K. Hemanth Kumar et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial
- (2015) Antonia M. I. Saktiawati et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
- (2015) Norbert Heinrich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis
- (2015) Justin Shenje et al. EBioMedicine
- Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
- (2014) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
- (2014) N. B. Bhatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
- (2014) Abdullah Alsultan et al. DRUGS
- Integrating drug concentrations and minimum inhibitory concentrations with Bayesian-dose optimisation for multidrug-resistant tuberculosis
- (2014) S. Srivastava et al. EUROPEAN RESPIRATORY JOURNAL
- Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin
- (2014) C. Magis-Escurra et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers
- (2014) Susanna E. Medellín-Garibay et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Impact of food intake on the pharmacokinetics of first-line antituberculosis drugs in Taiwanese tuberculosis patients
- (2014) Hsien-Chun Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Factors Associated with Variability in Rifampin Plasma Pharmacokinetics and the Relationship between Rifampin Concentrations and Induction of Efavirenz Clearance
- (2014) Awewura Kwara et al. PHARMACOTHERAPY
- Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS
- (2014) D.H. Vu et al. TALANTA
- Antitubercular therapy in patients with cirrhosis: Challenges and options
- (2014) Naveen Kumar WORLD JOURNAL OF GASTROENTEROLOGY
- A Case of Serum Sickness-Like Reaction and Anaphylaxis - Induced Simultaneously by Rifampin
- (2014) Dong-Hyun Kim et al. Allergy Asthma & Immunology Research
- Low rifampicin concentrations in tuberculosis patients with HIV infection
- (2014) Tanuja Narayansamy Gengiah et al. Journal of Infection in Developing Countries
- Plasma Concentrations of Isoniazid and Rifampin Are Decreased in Adult Pulmonary Tuberculosis Patients with Diabetes Mellitus
- (2013) Aylin Babalik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients
- (2013) Erlina Burhan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
- (2012) Helen McIlleron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
- (2012) Wynand Smythe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence
- (2012) M. F. Franke et al. CLINICAL INFECTIOUS DISEASES
- Dried Blood Spots: A New Tool for Tuberculosis Treatment Optimization
- (2012) D. H. Vu et al. CURRENT PHARMACEUTICAL DESIGN
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- TheSLCO1B1rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications
- (2011) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic drug monitoring in the treatment of tuberculosis patients
- (2011) Cecile Magis-Escurra et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The pharmacokinetics and pharmacodynamics of rifampicin in adults and children in relation to the dosage recommended for children
- (2011) P.R. Donald et al. TUBERCULOSIS
- The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial
- (2010) Marianne E Visser et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
- (2010) M. Weiner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Skin manifestations of drug allergy
- (2010) Michael R. Ardern-Jones et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The chemotherapy of tuberculous meningitis in children and adults
- (2010) P.R. Donald TUBERCULOSIS
- Cerebrospinal fluid concentrations of antituberculosis agents in adults and children
- (2010) P.R. Donald TUBERCULOSIS
- Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes
- (2009) R. Ruslami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
- (2009) S. Goutelle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Antimycobacterial Drugs in Patients with Both Tuberculosis and Advanced Human Immunodeficiency Virus Infection
- (2009) David P Holland et al. PHARMACOTHERAPY
- Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis
- (2008) C. S. WANG et al. EPIDEMIOLOGY AND INFECTION
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now